Genetic investigation for adults with intellectual disability: opportunities and challenges.

PURPOSE OF REVIEW This review discusses diagnostic genetic assessment for adults with idiopathic intellectual disability, considering the potential yields and limitations of currently available investigations. RECENT FINDINGS Genome-wide microarray analysis is now a routine diagnostic test. Estimated yields for clinically significant copy number variants in adults with idiopathic intellectual disability are at least 10%. The medical and neuropsychiatric phenotypes of recurrent genomic disorders are being established. Many single gene causes of intellectual disability have been identified, most notably for X-linked intellectual disability. Ascribing causality, determination of recurrence risk, and prognostication for rare or unique variants remain challenging. SUMMARY Clinical evaluation and investigations (both nongenetic and genetic) can yield an aetiological diagnosis for a growing proportion of individuals with intellectual disability. Not all adults with intellectual disability will ever have received such an assessment. Genetic diagnosis can provide an explanation for lifelong disabling cognitive disorder, guide prognosis, and highlight medical comorbidities. A key outcome is clarification of recurrence risk and facilitation of reproductive choices. However, there are limited data on the desirability and acceptability of genetic diagnosis amongst adult patients with intellectual disability and their families, and concern that ethical principles and practices may be changing without scrutiny. The decision to embark on diagnostic review requires careful consideration for each individual.

[1]  M. Kyllerman,et al.  Aetiology of severe mental retardation and further genetic analysis by high‐resolution microarray in a population‐based series of 6‐ to 17‐year‐old children , 2012, Acta paediatrica.

[2]  Z. Tümer,et al.  High frequency of rare copy number variants affecting functionally related genes in patients with structural brain malformations , 2011, Human mutation.

[3]  K. Devriendt,et al.  The causality of de novo copy number variants is overestimated , 2011, European Journal of Human Genetics.

[4]  Z. Stark,et al.  Pathogenic aberrations revealed exclusively by single nucleotide polymorphism (SNP) genotyping data in 5000 samples tested by molecular karyotyping , 2011, Journal of Medical Genetics.

[5]  Wei Chen,et al.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders , 2011, Nature.

[6]  L. Coin,et al.  Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus , 2011, Nature.

[7]  W. Theodore,et al.  Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism , 2011, Brain and Development.

[8]  T. Kleefstra,et al.  Kleefstra syndrome in three adult patients: Further delineation of the behavioral and neurological phenotype shows aspects of a neurodegenerative course , 2011, American journal of medical genetics. Part A.

[9]  Bassem A Bejjani,et al.  Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems , 2011, Genetics in Medicine.

[10]  R. Pfundt,et al.  Parental insertional balanced translocations are an important cause of apparently de novo CNVs in patients with developmental anomalies , 2011, European Journal of Human Genetics.

[11]  J. Gleeson,et al.  The ciliopathies in neuronal development: a clinical approach to investigation of Joubert syndrome and Joubert syndrome‐related disorders , 2011, Developmental medicine and child neurology.

[12]  R. Hennekam,et al.  Uncovering Genomic Causes of Co-Morbidity in Epilepsy: Gene-Driven Phenotypic Characterization of Rare Microdeletions , 2011, PloS one.

[13]  Mustafa Tekin,et al.  Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia. , 2011, American journal of human genetics.

[14]  Gregory M. Cooper,et al.  A Copy Number Variation Morbidity Map of Developmental Delay , 2011, Nature Genetics.

[15]  K. Devriendt,et al.  Practical guidelines for managing patients with 22q11.2 deletion syndrome. , 2011, The Journal of pediatrics.

[16]  I. Scheffer,et al.  Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology , 2011, Brain : a journal of neurology.

[17]  J. Moss,et al.  Recognition of Tuberous Sclerosis in Adult Women: Delayed Presentation With Life-Threatening Consequences , 2011, Annals of Internal Medicine.

[18]  Michael Wigler,et al.  Rare De Novo Variants Associated with Autism Implicate a Large Functional Network of Genes Involved in Formation and Function of Synapses , 2011, Neuron.

[19]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[20]  Matthew R. G. Taylor,et al.  Natural history of Danon disease , 2011, Genetics in Medicine.

[21]  P. Stankiewicz,et al.  Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. , 2011, Human molecular genetics.

[22]  Y. Lunsky,et al.  Primary care of adults with developmental disabilities: Canadian consensus guidelines. , 2011, Canadian family physician Medecin de famille canadien.

[23]  Bradley P. Coe,et al.  Comparison of genome-wide array genomic hybridization platforms for the detection of copy number variants in idiopathic mental retardation , 2011, BMC Medical Genomics.

[24]  R. Huganir,et al.  Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. , 2011, American journal of human genetics.

[25]  C. Haldeman-Englert,et al.  Genes and biological processes commonly disrupted in rare and heterogeneous developmental delay syndromes. , 2011, Human molecular genetics.

[26]  C. Mathers,et al.  Prevalence of intellectual disability: a meta-analysis of population-based studies. , 2011, Research in developmental disabilities.

[27]  S. Schwartz,et al.  Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay , 2011, Human Genetics.

[28]  N. Kohli,et al.  Aetiology of intellectual disability in paediatric outpatients in Northern India , 2011, Developmental medicine and child neurology.

[29]  J. Schoumans,et al.  High‐resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting , 2011, Clinical genetics.

[30]  Y. Fukushima,et al.  Clinical application of array-based comparative genomic hybridization by two-stage screening for 536 patients with mental retardation and multiple congenital anomalies , 2011, Journal of Human Genetics.

[31]  Mark F Bear,et al.  Toward fulfilling the promise of molecular medicine in fragile X syndrome. , 2011, Annual review of medicine.

[32]  Lawrence H. Uricchio,et al.  Exome sequencing reveals a novel mutation for autosomal recessive non-syndromic mental retardation in the TECR gene on chromosome 19p13. , 2011, Human molecular genetics.

[33]  J. Gleeson,et al.  Genetic regulation of human brain development: lessons from Mendelian diseases , 2010, Annals of the New York Academy of Sciences.

[34]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[35]  J. D. den Dunnen,et al.  Experiences with array-based sequence capture; toward clinical applications , 2010, European Journal of Human Genetics.

[36]  T. Walsh,et al.  MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. , 2010, American journal of human genetics.

[37]  J. Clayton-Smith,et al.  Identification of genomic loci contributing to agenesis of the corpus callosum , 2010, American journal of medical genetics. Part A.

[38]  Stephan J Sanders,et al.  Whole exome sequencing identifies recessive WDR62 mutations in severe brain malformations , 2010, Nature.

[39]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[40]  Michael R. Johnson,et al.  Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. , 2010, American journal of human genetics.

[41]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[42]  R. Guerrini,et al.  Neuronal migration disorders , 2010, Neurobiology of Disease.

[43]  Ulrich Stephani,et al.  Genome-Wide Copy Number Variation in Epilepsy: Novel Susceptibility Loci in Idiopathic Generalized and Focal Epilepsies , 2010, PLoS genetics.

[44]  Nicola Brunetti-Pierri,et al.  Copy number variants at Williams–Beuren syndrome 7q11.23 region , 2010, Human Genetics.

[45]  J. Trojanowski,et al.  A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. , 2010, Brain : a journal of neurology.

[46]  P. Stankiewicz,et al.  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.

[47]  Deborah L. Levy,et al.  A recurrent 16p12.1 microdeletion suggests a two-hit model for severe developmental delay , 2010, Nature Genetics.

[48]  R. Pfundt,et al.  The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype , 2010, European Journal of Human Genetics.

[49]  P. Stankiewicz,et al.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size , 2009, Journal of Medical Genetics.

[50]  Laurence Faivre,et al.  Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. , 2009, Archives of general psychiatry.

[51]  L. Pasquier,et al.  Cryptic genomic imbalances in de novo and inherited apparently balanced chromosomal rearrangements: array CGH study of 47 unrelated cases. , 2009, European journal of medical genetics.

[52]  J. Gécz,et al.  The genetic landscape of intellectual disability arising from chromosome X. , 2009, Trends in genetics : TIG.

[53]  Andrew Menzies,et al.  A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation , 2009, Nature Genetics.

[54]  J. Gécz,et al.  Lessons learnt from large-scale exon re-sequencing of the X chromosome , 2009, Human molecular genetics.

[55]  B. V. van Bon,et al.  Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome , 2009, Journal of Medical Genetics.

[56]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[57]  R. Pfundt,et al.  Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype , 2009, Journal of Medical Genetics.

[58]  Michael P. Stryker,et al.  Reversing Neurodevelopmental Disorders in Adults , 2008, Neuron.

[59]  W. Otten,et al.  The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life , 2008, Psycho-oncology.

[60]  L. Vissers,et al.  Clinical and molecular delineation of the 17q21.31 microdeletion syndrome , 2008, Journal of Medical Genetics.

[61]  C. Romano,et al.  Further Delineation of Deletion 1p36 Syndrome in 60 Patients: A Recognizable Phenotype and Common Cause of Developmental Delay and Mental Retardation , 2008, Pediatrics.

[62]  N. Carter.  Methods and strategies for analyzing copy number variation using DNA microarrays , 2007, Nature Genetics.

[63]  F. Tyrer,et al.  Mortality in adults with moderate to profound intellectual disability: a population-based study. , 2007, Journal of intellectual disability research : JIDR.

[64]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[65]  F. Huppert,et al.  Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population‐based study , 2006, International journal of geriatric psychiatry.

[66]  L. Shaffer,et al.  American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation , 2005, Genetics in Medicine.

[67]  A. Majnemer,et al.  Developmental and Functional Outcomes at School Age of Preschool Children With Global Developmental Delay , 2005, Journal of child neurology.

[68]  B. D. de Vries,et al.  3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. , 2005, American journal of human genetics.

[69]  A. Hunter.  Outcome of the routine assessment of patients with mental retardation in a genetics clinic. , 2000, American journal of medical genetics.

[70]  S Schwartz,et al.  Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. , 1997, American journal of medical genetics.

[71]  Martin Offringa,et al.  Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness , 2005, European Journal of Human Genetics.

[72]  M. Durkin.  The epidemiology of developmental disabilities in low-income countries. , 2002, Mental retardation and developmental disabilities research reviews.

[73]  A. Battaglia,et al.  Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an institute of child neuropsychiatry. , 1999, American journal of medical genetics.

[74]  S. Ashwal,et al.  Subcommittee of the American Academy of Neurology and the Global Developmental Delay : Report of the Quality Standards Evidence Report: Genetic and Metabolic Testing on Children With , 2022 .

[75]  Alcino J. Silva,et al.  Effect of Simvastatin on Cognitive Functioning in Children with Neurofibromatosis Type 1 a Randomized Controlled Trial , 2022 .